Persistent URL of this record https://hdl.handle.net/1887/87142
Documents
-
- Download
- 10.1158_1078-0432.CCR-17-3512
- Not Applicable (or Unknown)
- open access
- Full text at publishers site
In Collections
This item can be found in the following collections:
Telatinib Is an Effective Targeted Therapy for Pseudomyogenic Hemangioendothelioma
- All authors
- IJzendoorn, D.G.P. van; Sleijfer, S.; Gelderblom, H.; Eskens, F.A.L.M.; Leenders, G.J.L.H. van; Szuhai, K.; Bovee, J.V.M.G.
- Date
- 2018-06-01
- Journal
- Clinical Cancer Research
- Volume
- 24
- Issue
- 11
- Pages
- 2678 - 2687